Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
360 stocks in the US match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| IMR.AX | Imricor Medical Systems, Inc. | Healthcare | $498.58M | 1.95 AUD | −13.56% | +0.78% |
| SENS | Senseonics Holdings, Inc. | Healthcare | $493.84M | $9.34 | −19.34% | +90.22% |
| EDIT | Editas Medicine, Inc. | Healthcare | $488.38M | $3.18 | −29.91% | +21.37% |
| NRC | NRC Health | Healthcare | $487.06M | $22.00 | −7.09% | −1.52% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| RLMD | Relmada Therapeutics, Inc. | Healthcare | $485.35M | $4.55 | −43.13% | −13.00% |
| RZLT | Rezolute, Inc. | Healthcare | $485.31M | $5.04 | −56.01% | +2.44% |
| PACB | Pacific Biosciences of California, Inc. | Healthcare | $484.90M | $1.56 | −42.86% | +12.23% |
| CAPR | Capricor Therapeutics, Inc. | Healthcare | $481.97M | $9.36 | −76.81% | +42.47% |
| QTTB | Q32 Bio Inc. | Healthcare | $481.67M | $16.18 | −31.35% | +2.99% |
| OCGN | Ocugen, Inc. | Healthcare | $478.15M | $1.41 | −48.26% | +13.71% |
| PBYI | Puma Biotechnology, Inc. | Healthcare | $472.84M | $9.16 | −3.68% | +14.93% |
| SGHT | Sight Sciences, Inc. | Healthcare | $458.33M | $8.37 | −9.38% | +57.92% |
| BIOA | BioAge Labs, Inc. | Healthcare | $451.63M | $9.84 | −62.09% | −55.11% |
| ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | $449.94M | $15.83 | −34.51% | +175.30% |
| BNTC | Benitec Biopharma Inc. | Healthcare | $442.48M | $12.88 | −23.15% | +8.33% |
| AVIR | Atea Pharmaceuticals, Inc. | Healthcare | $441.93M | $5.51 | −14.57% | +22.17% |
| CARL | Carlsmed, Inc. | Healthcare | $441.76M | $16.18 | −6.09% | +31.44% |
| CMPX | Compass Therapeutics, Inc. | Healthcare | $437.61M | $2.43 | −64.68% | +19.12% |
| LRMR | Larimar Therapeutics, Inc. | Healthcare | $432.15M | $4.17 | −35.05% | +8.88% |
| EYPT | EyePoint, Inc. | Healthcare | $430.20M | $4.99 | −73.89% | −58.28% |
| FRX.TO | Fennec Pharmaceuticals Inc. | Healthcare | $429.52M | 17.00 CAD | −3.63% | +21.86% |
| MASS | 908 Devices Inc. | Healthcare | $428.63M | $10.37 | −7.81% | +47.51% |
| CCRN | Cross Country Healthcare Inc | Healthcare | $428.06M | $13.25 | −11.61% | 0.00% |
| FENC | Fennec Pharmaceuticals Inc. | Healthcare | $426.77M | $12.17 | −8.15% | +22.43% |
| LXEO | Lexeo Therapeutics, Inc. | Healthcare | $420.90M | $5.01 | −54.41% | +14.12% |
| GALT | Galectin Therapeutics Inc. | Healthcare | $418.53M | $4.15 | −41.80% | +22.42% |
| XFOR | X4 Pharmaceuticals, Inc. | Healthcare | $412.45M | $4.17 | −13.66% | +6.11% |
| ENTA | Enanta Pharmaceuticals, Inc. | Healthcare | $412.12M | $14.15 | −17.49% | +12.21% |
| RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | $401.78M | $3.66 | −32.84% | +16.56% |
| PRTC.L | PureTech Health plc | Healthcare | $398.28M | 121.20 GBP | −15.60% | +0.17% |
| FHTX | Foghorn Therapeutics Inc. | Healthcare | $397.29M | $6.69 | −12.09% | +30.41% |
| OFIX | Orthofix Medical Inc. | Healthcare | $397.14M | $9.75 | −42.61% | −20.47% |
| TBRG | TruBridge Inc | Healthcare | $393.58M | $26.24 | −1.02% | 0.00% |
| IPSC | Century Therapeutics, Inc. | Healthcare | $392.93M | $2.14 | −29.61% | +4.39% |
| UPB | Upstream Bio, Inc. | Healthcare | $390.52M | $7.13 | −78.83% | +11.41% |
| TKNO | Alpha Teknova, Inc. | Healthcare | $387.63M | $7.22 | −7.91% | +41.85% |
| E2NO34.SA | Enovis Corporation | Healthcare | $387.44M | 34.59 BRL | −20.00% | +7.86% |
| MOBI | Mobia Medical, Inc. | Healthcare | $387.35M | $11.65 | −23.81% | +8.68% |
| SLP | Simulations Plus, Inc. | Healthcare | $372.34M | $18.41 | −12.38% | +0.44% |
| AGEN | Agenus Inc. | Healthcare | $371.33M | $8.25 | −6.78% | +25.00% |
| PALI | Palisade Bio, Inc. | Healthcare | $371.20M | $2.13 | −25.52% | +5.45% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Healthcare | $368.27M | $3.89 | −44.03% | −15.80% |
| LYEL | Lyell Immunopharma, Inc. | Healthcare | $362.68M | $15.49 | −65.58% | +19.25% |
| DMAC | DiaMedica Therapeutics Inc. | Healthcare | $361.30M | $6.70 | −35.70% | +0.90% |
| CATX | Perspective Therapeutics, Inc. | Healthcare | $360.72M | $3.16 | −48.70% | +10.10% |
| STRO | Sutro Biopharma, Inc. | Healthcare | $355.50M | $21.43 | −51.13% | −9.69% |
| VMD | Viemed Healthcare, Inc. | Healthcare | $355.36M | $9.33 | −26.01% | −21.73% |
| SABS | SAB Biotherapeutics, Inc. | Healthcare | $353.03M | $3.88 | −24.66% | +12.46% |
| IKT | Inhibikase Therapeutics, Inc. | Healthcare | $347.44M | $2.49 | −1.97% | +7.79% |
| ABEO | Abeona Therapeutics Inc. | Healthcare | $343.68M | $6.01 | −21.44% | −0.17% |
| IMRX | Immuneering Corporation | Healthcare | $333.19M | $5.15 | −48.91% | +21.46% |
| P2OD34.SA | Insulet Corporation | Healthcare | $332.45M | 24.68 BRL | −26.24% | −12.58% |
| RCEL | AVITA Medical, Inc. | Healthcare | $327.52M | $10.59 | −1.67% | +129.72% |
| AVH.AX | AVITA Medical, Inc. | Healthcare | $324.65M | 2.87 AUD | −2.88% | +117.05% |
| VNDA | Vanda Pharmaceuticals Inc. | Healthcare | $323.48M | $5.35 | −46.18% | +3.68% |
| SMTI | Sanara MedTech Inc. | Healthcare | $318.55M | $34.65 | −3.62% | +30.07% |
| OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | $316.15M | $5.26 | −9.00% | +36.27% |
| IRD | Opus Genetics, Inc. | Healthcare | $316.14M | $3.80 | −34.60% | +11.44% |
| RNAC | Cartesian Therapeutics, Inc. | Healthcare | $308.30M | $10.19 | −13.64% | +33.20% |
| TMCI | Treace Medical Concepts, Inc. | Healthcare | $306.96M | $4.72 | −39.33% | +17.71% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.